0.02Open0.01Pre Close40 Volume882 Open Interest173.00Strike Price80.00Turnover233.07%IV17.89%PremiumNov 15, 2024Expiry Date0.00Intrinsic Value100Multiplier0DDays to Expiry0.02Extrinsic Value100Contract SizeAmericanOptions Type0.0065Delta0.0019Gamma7338.00Leverage Ratio-0.2667Theta0.0000Rho48.04Eff Leverage0.0008Vega
NVIDIA Stock Discussion
Hugely Undervalued $2 Biotech With 21% Held Short $16 Price Target, Takeover Candidate, Soon Profitable. Fund that owns $Viking Therapeutics (VKTX.US)$ since 2022 below $10 a share is also investing in ESPR and expects the company will be a block buster.
This unique biotech $Esperion Therapeutics (ESPR.US)$ Esper...
the strategy today is
long TSLA and short NVDA
I mean break …. down
looking at green cloud up a head potential to shoot through
No comment yet